Synthetic resins or natural rubbers -- part of the class 520 ser – Synthetic resins – Mixing of two or more solid polymers; mixing of solid...
Reexamination Certificate
2003-03-18
2011-11-15
Anderson, James D (Department: 1629)
Synthetic resins or natural rubbers -- part of the class 520 ser
Synthetic resins
Mixing of two or more solid polymers; mixing of solid...
C424S078270
Reexamination Certificate
active
08058344
ABSTRACT:
The present invention relates to new anionic glycodendrimers having new biological activity, processes for preparing them and their use in medicine including veterinary medicine.
REFERENCES:
patent: 5338532 (1994-08-01), Tomalia et al.
patent: 5527524 (1996-06-01), Tomalia et al.
patent: 5560929 (1996-10-01), Hedstrand et al.
patent: 5714166 (1998-02-01), Tomalia et al.
patent: 6177414 (2001-01-01), Tomalia et al.
patent: 6190650 (2001-02-01), Matthews et al.
patent: 6312679 (2001-11-01), Tomalia et al.
patent: 2003/0114418 (2003-06-01), Pulaski et al.
patent: 2010/0173871 (2010-07-01), Poupot et al.
patent: WO 88/01178 (1988-02-01), None
patent: WO 91/11172 (1991-08-01), None
patent: WO 94/02518 (1994-02-01), None
patent: WO 95/24221 (1995-09-01), None
patent: WO 95/34595 (1995-12-01), None
patent: WO 98/55148 (1998-12-01), None
patent: WO98/56353 (1998-12-01), None
patent: WO 02/00196 (2002-01-01), None
patent: WO 03/089010 (2003-10-01), None
patent: WO2007/045009 (2007-04-01), None
patent: WO2007/045010 (2007-04-01), None
patent: WO2007/048190 (2007-05-01), None
patent: WO2007/082331 (2007-07-01), None
patent: WO2008/017122 (2008-02-01), None
patent: WO 2008/017125 (2008-02-01), None
patent: WO2009/004639 (2009-01-01), None
patent: WO 2009/103123 (2009-08-01), None
Cloninger, Curr Opin Chem Biochem, 6:742-748. 2002.
Rockendorf et al. (Topics in Current Chemistry, 217: 2001.
Lam et al., J. Polym, Res., vol. 6 (4): 203-210, 1999.
Zanini and Roy, “Novel Dendritic α-Sialosides: Synthesis of Glycodenrimers Based on a 3,3′-Iminobis(propylamine) Core”, Journal of Organic Chemistry, vol. 61, pp. 7348-7354; 1996.
Brewer, “Lectin Cros-Linking Interactions with Multivalent Carbohydrates”, In “The Molecular Immunology of Complex Carbohydrates—2”, editor Wu, Kluwer Academic/Plenum Publishers, 2001.
Tomalia et al., Angewandte Chemie-International Edition in English, 1990, vol. 29, pp. 138-175.
Newkome et al., Journal of Organic Chemistry, 1992, vol. 57, pp. 358-362.
Jansen et al., Science, 1994, vol. 266, pp. 1226-1229.
Page and Roy, Bioconjugate Chemistry, 1997, vol. 8, pp. 714-723.
Ashton et al., Chemistry A European Journal, 1997, vol. 3, pp. 974-984.
Malik et al., Journal of Controlled Release, 2000, vol. 65, pp. 133-148.
Tsutsumiuchi et al. Polymer Journal, 1999, vol. 31, pp. 935-941 (Abstract only).
Shaunak et al. Nature Biotechnology, 2004, vol. 22, pp. 977-984, Supl. pp. 1-10.
Aghezedeh-Habashi et al, J Pharm Pharmaceut Sci 5(2):181-184, 2002 Single Dose Pharmacokinetics and Bioavailability of Glucosamine in the Rat.
Atala A et al., MRS Bulletin Aug. 2010; 35: 597-606, Wound healing versus regeneration: Role of the tissue environment in regenerative medicine.
Ashton PR et al, Chem. Eur. J. 1997; 3(6): 974-984, Synthesis of glycodendrimers by modification of poly(propylene imine) dendrimers.
Balan et al, Bioconjugate Chem. 2007, 18 61-76, Site-Specific PEGylation of Protein Disulfide Bonds Using a Three-Carbon Bridge.
Bauer J et al, Cellular Physiology 1992 153: 437-449, In vitro model of angiogenesis using human endothelium derived from permanent cell line.
Brewer et al, The Molecular Immunology of Complex Carbohydrates—2 Editor Wu, Kluwer Academic/Plenum Publishers, 2001, Lectin Cross-Linking Interactions with Multivalent Carbohydrates.
Boyd BJ et al, Mol Pharm 2006;3 No. 5, 614-627, Cationic Poly-L-lysine Dendrim.
Brandtzaeg et al, J. Exp. Med. vol. 184 Jul. 1996 51-60, Net Inflammatory Capacity of Human Septic Shock Plasma Evaluated by a Monocyte-based Target Cell Assay: Identification of Interleukin-10 as a Major Functional Deactivator o f Human Monocytes.
Bryant et al, Nature Reviews Microbiology vol. 8 Jan. 2010, The molecular basis of the host response to lipopolysaccharide.
Chang et al, Survey of Ophthalmology vol. 45 No. 1 Jul.-Aug. 2000, The Role of the Immune System in Conjunctival Wound Healing After Glaucoma Surgery.
Chen et al, J. Am. Chem. Soc 2004, 126, 10044-10048, Cytotoxicity, Hemolysis and Acute in Vivo Toxicity of Dendrimers Based on Melamine, Candidate Vehicles for Drug Delivery.
Chouai A et al, J. Organic Chemistry 2008; 73(6): 2357-2366, Kilogram-Scale Sythesis of a Second-Gneration Dendrimer Based 1,3,5-Triazine Using Green and Industrially Compatible Methods with a Single Chromatographic Step.
Choy et al, N Engl J Med, vol. 344, No. 12 Mar. 22, 2001, Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis.
Cloninger, Current Opinion in Chemical Biology 2002, 6:742-748, Biological applications of dendrimers.
Cordeiro et al, Investigative Opthamology and Visual Science 1999 40 2225-34, Human Anti-Transforming Growth Factor-b2 Antibody: A New Glaucoma Anti-Scarring Agent.
Duncan, Nature Reviews Drug Discovery vol. 2 May 2003 347-60, The Dawning Era of Polymer Therapeutics.
Flo et al, The Journal of Biological Chemistry vol. 277, No. 38, pp. 35489-35495, 2002, Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers.
Fukasawa et al, Journal of Surgical Research 1989, 46(2), 166-71, Modulation of proline and glucosamine incorporation into tissue repair cells by peritoneal macrophages.
Garcia-Ramallo et al, The Journal of Immunology 2002;169;6467-6473, Resident Cell Chemokine Expression Serves as the Major Mechanism for Leukocyte Recruitment During Local Inflammation.
Gaspar et al, Advance Drug Delivery Reviews 61 (2009) 1220-1231, Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics.
Girard & Springer, Immunology Today 1995 16(9) 449-57, High endothelial venules (HEVs): specialized endothelium for lymphocyte migration.
Gordon, Cell, vol. 111, 927-930, Dec. 27, 2002, Pattern Recognition Receptors: Doubling Up for the Innate Immune Response.
Hollink E et al, Org Lett 2006;8:2293-2295, A Divergent Route to Diversity in Macromolecule.
Hourani et al, Macromol. Rapid Commun. 2010; 31: 947-974, Advances in the elegance of chemistry in designing dendrimers.
Hoshino et al,J. Immunol. 1999;162;3749-3752, Cutting Edge: Toll-Like Receptor 4 (TLR4)-Deficient Mice Are Hyporesponsive to Lipopolysaccharide: Evidence for TLR4 as theLpsGene Product.
Jansen JFGA, Science Nov. 18, 1994:vol. 266. No. 5188, pp. 1226-1229, Encapsulation of guest molecules into a dendritic Box.
Jayamurugan G et al, Tetrahedron 62 (2006) 9582-9588, Sythesis of large generation poly(propyl ehter imine) (PETIM) dendrimers.
Jerala R, International Jounral of Medical Microbiology 297 (2007) 353-363, Structural Biology of the LPS recognition.
Jevprasesphant et al,Pharmaceutical Research, vol. 20, No. 10, Oct. 2003, Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity.
Jiang Z et al, Nat Immunol 2005;6:565-569, CD12 is required for MyD88-independent LPS signalling.
Johnson et al,J. Immunol. 2004;172;20-24, Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 4.
Kagan et al, Nature Immunology vol. 9 No. 4 Apr. 2008, TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.
Karlsson et al, Infection and Immunity May 2004 p. 2671-2678, Paterrn of Cytokine Responses to Gram-Positive and Gram-Negative Commensal Bacteria Is Profoundly Changed when Monocytes Differentiate into Dendritic Cells.
Khaw et al, Ophthalmology. Mar. 1993;100(3):367-72, Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit.
Kopf et al, Nature Reviews Drug Discovery vol. 9 Sep. 2010 703, Averting inflammation by targeting the cytokine environment.
Koyanagi et al, Biochemical Pharmacology 65 2003 173-9, Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.
Krishna T et al, J. Org Chem 2003, 68, 9694-9704, Synthesis of Poly(propyl ether imine) Dendrimers and Evaluation of Their Cytotoxic Properties.
Krishna T et al, Tetrahedron 2005; 61: 4281-4288, Synthesis and biological evaluation of 3-amino-propanol-1-ol based poly(ether imine) dend
Duncan Ruth
Gianasi Elisabetta
Shaunak Sunil
Anderson James D
Baek Bong-Sook
Imperial Innovations Ltd
Nixon & Vanderhye P.C.
LandOfFree
Glycodendrimers having biological activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycodendrimers having biological activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycodendrimers having biological activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4255395